Antioxidants
(Unterschied zwischen Versionen)
| Zeile 12: | Zeile 12: | ||
'''NAC''' | '''NAC''' | ||
{{tp|p=32344315|t=2020. N-acetyl-cysteine may prevent COVID-19-associated cytokine storm and acute respiratory distress syndrome |pdf=|usr=}} | {{tp|p=32344315|t=2020. N-acetyl-cysteine may prevent COVID-19-associated cytokine storm and acute respiratory distress syndrome |pdf=|usr=}} | ||
| − | + | {{tp|p=32345063|t=2020. Truncated IV acetylcysteine treatment duration has potential to safely preserve resources during the COVID-19 pandemic |pdf=|usr=}} | |
'''mix''' | '''mix''' | ||
{{tp|p=32321655|t=ä. An anti-oxidative therapy for ameliorating cardiac injuries of critically ill COVID-19-infected patients |pdf=|usr=}} | {{tp|p=32321655|t=ä. An anti-oxidative therapy for ameliorating cardiac injuries of critically ill COVID-19-infected patients |pdf=|usr=}} | ||
Version vom 18. Juni 2020, 12:57 Uhr
Glutathione GSH antioxidant
| 32322478 2020. Efficacy of glutathione therapy in relieving dyspnea associated with COVID-19 pneumonia: A report of 2 cases |
Vitamin C
32264963 2020. A new clinical trial to test high-dose vitamin C in patients with COVID-19
32328576 2020. Can early and high intravenous dose of vitamin C prevent and treat coronavirus disease 2019 (COVID-19)?
32322486 2020. Intravenous vitamin C for reduction of cytokines storm in acute respiratory distress syndrome
NAC
32344315 2020. N-acetyl-cysteine may prevent COVID-19-associated cytokine storm and acute respiratory distress syndrome
32345063 2020. Truncated IV acetylcysteine treatment duration has potential to safely preserve resources during the COVID-19 pandemic
mix
32321655 ä. An anti-oxidative therapy for ameliorating cardiac injuries of critically ill COVID-19-infected patients
